Back to Search
Start Over
Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration
- Source :
- Journal of Clinical Medicine, Vol 10, Iss 2052, p 2052 (2021), Journal of Clinical Medicine
- Publication Year :
- 2021
- Publisher :
- MDPI AG, 2021.
-
Abstract
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic neoplasms characterized by ineffective hematopoiesis and myelodysplasia with a variable spectrum of clinical–biological features that can be used to build a prognostic estimation. This review summarizes the current most widely used prognostic scoring systems and gives a general view of the prognostic impact of somatic mutations in MDS patients.
- Subjects :
- Oncology
Ineffective Hematopoiesis
clinical–genetic alterations
medicine.medical_specialty
business.industry
Myelodysplastic syndromes
Review
General Medicine
medicine.disease
myelodysplastic syndrome
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
hemic and lymphatic diseases
medicine
Medicine
Hematopoietic Neoplasms
business
prognostic impact
030215 immunology
Subjects
Details
- Language :
- English
- ISSN :
- 20770383
- Volume :
- 10
- Issue :
- 2052
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Medicine
- Accession number :
- edsair.doi.dedup.....8679c4e129f6e36fbe070459e313ebb9